Lou Gehrig Disease
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Speech Analysis in ALS Patients (NCT03868345) | Barrow Neurological Institute | 2019-02-18 |
| Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS (NCT03520517) | Biohaven Pharmaceuticals, Inc. | 2018-02-02 |
| Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS) (NCT03537807) | Biohaven Pharmaceuticals, Inc. |
Track Lou Gehrig Disease automatically
Every clearance here is in the API, with alerts when new ones post.